Ankeet Bhatt

NPI: 1952797581
Total Payments
$117,818
2024 Payments
$73,424
Companies
14
Transactions
59

Payment Breakdown by Category

Consulting$66,134 (56.1%)
Other$25,069 (21.3%)
Travel$22,814 (19.4%)
Food & Beverage$3,438 (2.9%)
Education$362.98 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $66,134 10 56.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $25,069 4 21.3%
Travel and Lodging $22,814 21 19.4%
Food and Beverage $3,438 20 2.9%
Education $362.98 4 0.3%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $60,816 21 $0 (2024)
SANOFI PASTEUR INC. $48,040 18 $0 (2024)
AstraZeneca Pharmaceuticals LP $3,005 4 $0 (2024)
Merck Sharp & Dohme LLC $2,363 1 $0 (2024)
AltaThera Pharmaceuticals LLC $1,763 2 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $1,043 1 $0 (2024)
Astellas Pharma US Inc $362.98 4 $0 (2021)
Bayer Healthcare Pharmaceuticals Inc. $104.10 1 $0 (2024)
Daxor Corporation $99.08 2 $0 (2023)
Janssen Pharmaceuticals, Inc $92.53 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $73,424 32 Novo Nordisk Inc ($42,029)
2023 $42,369 16 SANOFI PASTEUR INC. ($23,547)
2022 $153.35 2 Novo Nordisk Inc ($135.50)
2021 $685.75 3 SANOFI PASTEUR INC. ($596.00)
2020 $183.99 2 Astellas Pharma US Inc ($183.99)
2019 $1,001 4 SANOFI PASTEUR INC. ($809.48)

All Payment Transactions

59 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/09/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Consulting Fee Cash or cash equivalent $2,953.50 General
Category: Cardiovascular and Metabolism
11/17/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $5.59 General
11/16/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $32.72 General
10/16/2024 Novo Nordisk Inc Consulting Fee Cash or cash equivalent $12,206.25 General
10/16/2024 Novo Nordisk Inc Travel and Lodging In-kind items and services $936.51 General
10/16/2024 Novo Nordisk Inc Travel and Lodging In-kind items and services $302.54 General
10/16/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $274.56 General
10/16/2024 Novo Nordisk Inc Travel and Lodging In-kind items and services $224.70 General
09/20/2024 Novo Nordisk Inc Consulting Fee Cash or cash equivalent $12,206.25 General
09/20/2024 Novo Nordisk Inc Travel and Lodging In-kind items and services $876.82 General
09/20/2024 Novo Nordisk Inc Travel and Lodging In-kind items and services $840.45 General
09/20/2024 Novo Nordisk Inc Travel and Lodging In-kind items and services $281.33 General
09/20/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $199.95 General
08/30/2024 SANOFI PASTEUR INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $16,592.00 General
08/30/2024 SANOFI PASTEUR INC. Consulting Fee In-kind items and services $985.66 General
08/30/2024 SANOFI PASTEUR INC. Travel and Lodging In-kind items and services $587.46 General
08/30/2024 SANOFI PASTEUR INC. Travel and Lodging Cash or cash equivalent $185.56 General
08/30/2024 SANOFI PASTEUR INC. Food and Beverage Cash or cash equivalent $159.83 General
08/30/2024 SANOFI PASTEUR INC. Food and Beverage In-kind items and services $105.14 General
06/14/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $1,042.67 General
Category: DIABETES
06/11/2024 SANOFI PASTEUR INC. Consulting Fee Cash or cash equivalent $4,471.50 General
06/01/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $43.52 General
Category: Cardiology
05/11/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $13.16 General
Category: Cardiovascular and Metabolism
04/13/2024 Novo Nordisk Inc Consulting Fee Cash or cash equivalent $12,206.25 General
04/13/2024 Novo Nordisk Inc Travel and Lodging In-kind items and services $665.79 General

About Ankeet Bhatt

Ankeet Bhatt is a Cardiovascular Disease healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2015. The National Provider Identifier (NPI) number assigned to this provider is 1952797581.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ankeet Bhatt has received a total of $117,818 in payments from pharmaceutical and medical device companies, with $73,424 received in 2024. These payments were reported across 59 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($66,134).

Practice Information

  • Specialty Cardiovascular Disease
  • Other Specialties Student in an Organized Health Care Education/Training Program
  • Location Durham, NC
  • Active Since 04/10/2015
  • Last Updated 10/08/2019
  • Taxonomy Code 207RC0000X
  • Entity Type Individual
  • NPI Number 1952797581

Products in Payments

  • FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological) $15,598
  • LOKELMA (Drug) $2,967
  • Sotalol Hydrochloride (Drug) $1,763
  • JARDIANCE (Drug) $1,043
  • NO PRODUCT DISCUSSED (Drug) $809.48
  • BVA-100 (Device) $99.08
  • XARELTO (Drug) $92.53
  • CORDELLA PULOMONARY ARTERY PRESSURE SENSOR (Device) $49.75
  • Repatha (Biological) $43.52
  • Inpefa (Drug) $27.50
  • Barostim Neo System (Device) $9.76

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Cardiovascular Disease Doctors in Durham